- Home
- AIMD vs NXPL Comparison
AIMD vs NXPL Comparison
Compare AIMD & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- NXPL
- Stock Information
- Founded
- AIMD 1984
- NXPL 1997
- Country
- AIMD United States
- NXPL United States
- Employees
- AIMD N/A
- NXPL N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- AIMD Health Care
- NXPL Telecommunications
- Exchange
- AIMD Nasdaq
- NXPL Nasdaq
- Market Cap
- AIMD 16.9M
- NXPL 17.9M
- IPO Year
- AIMD N/A
- NXPL N/A
- Fundamental
- Price
- AIMD $3.43
- NXPL $0.86
- Analyst Decision
- AIMD
- NXPL
- Analyst Count
- AIMD 0
- NXPL 0
- Target Price
- AIMD N/A
- NXPL N/A
- AVG Volume (30 Days)
- AIMD 88.9K
- NXPL 129.9K
- Earning Date
- AIMD 11-05-2025
- NXPL 11-13-2025
- Dividend Yield
- AIMD N/A
- NXPL N/A
- EPS Growth
- AIMD N/A
- NXPL N/A
- EPS
- AIMD N/A
- NXPL N/A
- Revenue
- AIMD $110,870.00
- NXPL $58,766,000.00
- Revenue This Year
- AIMD N/A
- NXPL N/A
- Revenue Next Year
- AIMD N/A
- NXPL N/A
- P/E Ratio
- AIMD N/A
- NXPL N/A
- Revenue Growth
- AIMD 70.25
- NXPL N/A
- 52 Week Low
- AIMD $2.00
- NXPL $0.43
- 52 Week High
- AIMD $5.00
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- AIMD 49.24
- NXPL 66.23
- Support Level
- AIMD $3.30
- NXPL $0.69
- Resistance Level
- AIMD $3.61
- NXPL $0.74
- Average True Range (ATR)
- AIMD 0.26
- NXPL 0.05
- MACD
- AIMD -0.06
- NXPL 0.01
- Stochastic Oscillator
- AIMD 18.29
- NXPL 90.91
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.